Abiopharma

🔍 Phillips Scott A. (Executive)

Company: FIRST BUSEY CORP /NV/ (BUSE)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 1,046 shares of Common Stock at $20.315 per share (Direct)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 20,108.59 | transaction_form_type: 5 | Footnotes: F1
• Acquired 86 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 20,194.59 | transaction_form_type: 4 | Footnotes: F2
• Acquired 5,000 shares of Depositary Shares, 1/40 interest in Series B Preferred Stock at $25.9015 per share (Direct)
  Date: 2026-05-04 | Code: P | equity_swap_involved: 0 | shares_owned_after: 8,350.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Shares were acquired under the First Busey Corporation Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(c) and Rule 16b-3(d).
• F2: Represents dividend equivalent rights accrued on Restricted Stock Units in connection with the payment of a cash dividend on First Busey Corporation Common Stock. Each dividend equivalent right is the economic equivalent of one share of First Busey Corporation Common Stock.
• F3: Each Depositary Share represents a 1/40th interest in a share of the issuer's 8.25% Fixed-Rate Non-Cumulative Perpetual Preferred Stock, Series B, par value $0.01 per share.